Demeetra
Business Services · Kentucky, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2277 Thunderstick Dr Ste 500, Lexington,...Website
www.demeetra.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Demeetra
Demeetra AgBio specializes in advanced gene-editing technologies, including Cas-CLOVER and piggyBac® transposase, to engineer traits for life. Their integrated genome engineering platforms support commercial bioprocessing and discovery research, enabling precise genome edits and stable expression. The company targets biotechnology firms, contract development and manufacturing organizations (CDMOs), and research institutions, offering flexible licensing options and expert support throughout the product lifecycle. Demeetra's technologies are designed to accelerate discovery and scale production while ensuring freedom to operate in biologics manufacturing.Explore more
Demeetra Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Demeetra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Demeetra recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Demeetra, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Demeetra
Product Launch: Get notified when Demeetra launches new products
Website visits: Recent activity has been detected on your website
Click to see if Demeetra had a recent Job posting/layoffs
Check out if Demeetra is spiking on competitors!
Check if Demeetra has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Demeetra has new funding data
Recommended Actions
Find VP level buyers at Demeetra
Find 3 more new buyers
Compare Similar Companies to Demeetra
Compare insights from companies similar to Demeetra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Demeetra is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Demeetra is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Demeetra.
Demeetra financials insights
Gather financial insights about Demeetra, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$92K
Demeetra Tech Stack
A closer look at the technologies used by Demeetra
See more technologies
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Partnership
Partnership, Product Management, Business Development, Intellectual Property, Legal Affairs, Bioengineering, Medical Research
Event
Product Marketing, Events, Business Intelligence, Engineering, Analytics & Insights, Research & Development, Sales, Search, Software, Bioengineering, Laboratory Operations, Clinical Operations, Field Marketing, Operations
Event
Product Marketing, Events, Business Intelligence, Engineering, Analytics & Insights, Research & Development, Sales, Search, Software, Bioengineering, Laboratory Operations, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Demeetra News & Media
Demeetra Announces Renewal of piggyBac® Technology Research License by Eisai
Demeetra AgBio, Inc. (hereafter "Demeetra") today announced that the renewal of the research license agreement for the piggyBac® transposase technology, a widely used platform for genetic engineering in research applications, by Eisai Co., Ltd. (hereafter "Eisai") has taken place....Demeetra Announces Renewal of Research License for piggyBac® Technology with Taiho Pharmaceutical Co., Ltd.
Demeetra AgBio, Inc. (hereafter "Demeetra") today announced that Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho") has renewed its research license agreement for the piggyBac® transposase technology, a widely used platform for genetic engineering in research applications. LEXINGTON, Ky....Demeetra AgBio's CleanCut GS CHO Cells Achieve Dual Viral Clearance Validation, Confirming GMP-Ready Status
Dual viral clearance validation positions CleanCut GS CHO as a GMP-ready, high-productivity platform for biopharma and CDMOs. LEXINGTON, Ky., Nov. 11, 2025 /PRNewswire-PRWeb/ -- Demeetra announced today that its flagship CleanCut GS CHO cell line has tested clean on two independent viral...Demeetra’s Complementary Gene Editing Technologies Selected for Oral Presentation at ESACT 2024
LEXINGTON, Ky.--(BUSINESS WIRE)--Demeetra, a gene editing technologies company, is proud to announce that its research in collaboration with Variation Biosciences, Inc. “VBI” has been selected for an oral presentation at the prestigious European Society for Animal Cell Technology (ESACT) 2024 conference from June 23-26 in Ediburgh, Scotland. The presentation, titled "Complementary Gene Editing Technologies Enhance Rapid Generation of Stable Cell Lines Producing Enveloped Viral-Like Particles,"
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Demeetra
Sign Up For FreeTo access detailed company insights
Demeetra AgBio specializes in advanced gene-editing technologies, including Cas-CLOVER and piggyBac® transposase, to engineer traits for life. Their integrated genome engineering platforms support commercial bioprocessing and discovery research, enabling precise genome edits and stable expression. The company targets biotechnology firms, contract d... Read More
